AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35150156 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 0.9 mg daily for 6 months
Number of subjects: 78
Study 35150156 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo for 6 months
Number of subjects: 78
Study 33675156 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 1250mg TID for 4 weeks
Number of subjects: 15
Study 33675156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33675156 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 15
Study 32188111 — intervention group
Group type: EXPERIMENTAL
Intervention: Q10Vital® water-soluble CoQ10 syrup (investigational product)
Number of subjects: 21
Study 32188111 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubiquinol capsules (comparative product)
Number of subjects: 21
Study 32188111 — intervention group
Group type: COMPARATOR
Intervention: Ubiquinone capsules (standard product)
Number of subjects: 21
Study 34637524 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 2979
Study 34637524 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 2979
Study 34637524 — intervention group
Group type: COMPARATOR
Intervention: ILI vs DSE
Number of subjects: 2979
Study 33533908 — intervention group
Group type: EXPERIMENTAL
Intervention: CASSY (Computerized Adaptive Screen for Suicidal Youth)
Number of subjects: 4829
Study 35025537 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 300
Study 35025537 — intervention group
Group type: COMPARATOR
Intervention: Behavioral Activation (BA)
Number of subjects: 300
Study 35025537 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudden Gains
Number of subjects: 300
Study 35025537 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression Spikes
Number of subjects: 300
Study 32202330 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg/day Zataria multiflora extract (Z3) for 2 months
Number of subjects: 45
Study 32202330 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg/day Zataria multiflora extract (Z6) for 2 months
Number of subjects: 45
Study 32202330 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 45
Study 35457683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemonoxacin
Number of subjects: 0
Study 35457683 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 0
Study 35457683 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin
Number of subjects: 0
Study 35457683 — intervention group
Group type: COMPARATOR
Intervention: Nemonoxacin vs Moxifloxacin
Number of subjects: 0
Study 35457683 — intervention group
Group type: COMPARATOR
Intervention: Nemonoxacin vs Moxifloxacin for PTB misdiagnosed as CAP
Number of subjects: 0
Study 35457683 — intervention group
Group type: COMPARATOR
Intervention: Nemonoxacin vs Levofloxacin for PTB misdiagnosed as CAP
Number of subjects: 0
Study 32107487 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA (target-controlled infusion of propofol and remifentanil)
Number of subjects: 121
Study 32107487 — intervention group
Group type: COMPARATOR
Intervention: BGA (continuous remifentanil infusion and sevoflurane inhalation)
Number of subjects: 121
Study 34955446 — intervention group
Group type: EXPERIMENTAL
Intervention: GO2 Frailty Score (GO2FS) ≥3 ('severely frail')
Number of subjects: 514
Study 34955446 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Rockwood Clinical Frailty Scale (mCFS) 5+ ('frail')
Number of subjects: 514
Study 34955446 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric-8 (G8) > 14 ('normal')
Number of subjects: 514
Study 34955446 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOG Performance Status (PS)
Number of subjects: 514
Study 34955446 — intervention group
Group type: EXPERIMENTAL
Intervention: CARG toxicity score
Number of subjects: 514
Study 35094007 — intervention group
Group type: EXPERIMENTAL
Intervention: Exoskeleton gait training (12 weeks, 36 sessions)
Number of subjects: 25
Study 35094007 — intervention group
Group type: COMPARATOR
Intervention: Active Control (standard gait training or no gait training)
Number of subjects: 25
Study 35094007 — intervention group
Group type: COMPARATOR
Intervention: Passive Control (no gait training)
Number of subjects: 25
Study 32522698 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine ≥3 mg
Number of subjects: 52
Study 32522698 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine <3 mg
Number of subjects: 52
Study 32522698 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors
Number of subjects: 52
Study 32522698 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 52
Study 32522698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral performance category (CPC) score
Number of subjects: 52
Study 32522698 — intervention group
Group type: EXPERIMENTAL
Intervention: iFABP levels
Number of subjects: 52
Study 32522698 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurological outcome
Number of subjects: 52
Study 35364333 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirkus Empathico (ZE)
Number of subjects: 82
Study 35364333 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 82
Study 34544415 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF)
Number of subjects: 571
Study 34544415 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Facility Financing (DFF)
Number of subjects: 571
Study 34544415 — intervention group
Group type: COMPARATOR
Intervention: Business-as-usual
Number of subjects: 571
Study 32708831 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG)
Number of subjects: 23
Study 32708831 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 23
Study 37306651 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter edge‐to‐edge repair (TEER) with MitraClip plus guideline‐directed medical therapy (GDMT)
Number of subjects: 552
Study 37306651 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 552
Study 37306651 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter edge‐to‐edge repair (TEER) with MitraClip plus GDMT
Number of subjects: 552
Study 34629244 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid ring
Number of subjects: 308
Study 34629244 — intervention group
Group type: COMPARATOR
Intervention: Flexible band
Number of subjects: 308
Study 32265346 — intervention group
Group type: EXPERIMENTAL
Intervention: Subomohyoid Anterior Suprascapular Block
Number of subjects: 0
Study 32265346 — intervention group
Group type: COMPARATOR
Intervention: Interscalene Block
Number of subjects: 0
Study 35503145 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face mindfulness training (n=40)
Number of subjects: 102
Study 35503145 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based Student Compass program (n=22)
Number of subjects: 102
Study 35503145 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=40)
Number of subjects: 102
Study 35503145 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness practice at least twice a week
Number of subjects: 102
Study 33856355 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality walking trails with audio-recorded education
Number of subjects: 72
Study 33856355 — intervention group
Group type: COMPARATOR
Intervention: Standard of care therapy
Number of subjects: 72
Study 34779137 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy with 5% lavender oil
Number of subjects: 58
Study 34779137 — intervention group
Group type: COMPARATOR
Intervention: Placebo massage therapy with baby oil
Number of subjects: 58
Study 33882563 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconium dioxide (ZrO2) crowns
Number of subjects: 44
Study 33882563 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium disilicate (LDS) crowns
Number of subjects: 44
Study 33882563 — intervention group
Group type: EXPERIMENTAL
Intervention: All crowns (ZrO2 and LDS combined)
Number of subjects: 44
Study 35285912 — intervention group
Group type: EXPERIMENTAL
Intervention: IRF-40 (40 mg iron/d)
Number of subjects: 240
Study 35285912 — intervention group
Group type: EXPERIMENTAL
Intervention: IRF-20 (20 mg iron/d)
Number of subjects: 240
Study 35285912 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study 33798801 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison to attractive Instagram models
Number of subjects: 142
Study 33798801 — intervention group
Group type: COMPARATOR
Intervention: Appearance-neutral control condition
Number of subjects: 142
Study 32320131 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental International Consultation on Incontinence Questionnaire-Satisfaction (dICIQ-S)
Number of subjects: 410
Study 32320131 — intervention group
Group type: EXPERIMENTAL
Intervention: dICIQ-S
Number of subjects: 410
Study 33146831 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical reading training for patients with right HFD
Number of subjects: 21
Study 33146831 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal reading training for patients with left HFD
Number of subjects: 21
Study 33146831 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical reading training
Number of subjects: 21
Study 33146831 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal reading training
Number of subjects: 21
Study 32122312 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized linear mixed model (GLMM)
Number of subjects: 0
Study 32122312 — intervention group
Group type: COMPARATOR
Intervention: Complete case Ï‡2 test
Number of subjects: 0
Study 35596636 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B2
Number of subjects: 57
Study 35596636 — intervention group
Group type: EXPERIMENTAL
Intervention: β-carotene
Number of subjects: 57
Study 35596636 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol (Vitamin A)
Number of subjects: 57
Study 35596636 — intervention group
Group type: EXPERIMENTAL
Intervention: α-tocopherol (Vitamin E)
Number of subjects: 57
Study 35596636 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 57
Study 35596636 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C and E
Number of subjects: 57
Study 35596636 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B1 and B2 urinary excretion
Number of subjects: 57
Study 35126302 — intervention group
Group type: EXPERIMENTAL
Intervention: Med–STN+GPi–
Number of subjects: 8
Study 35126302 — intervention group
Group type: EXPERIMENTAL
Intervention: Med–STN–GPi+
Number of subjects: 8
Study 35126302 — intervention group
Group type: EXPERIMENTAL
Intervention: Med+STN+GPi–
Number of subjects: 8
Study 35126302 — intervention group
Group type: EXPERIMENTAL
Intervention: Med+STN–GPi+
Number of subjects: 8
Study 36280934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical stabilisation exercises
Number of subjects: 44
Study 36280934 — intervention group
Group type: COMPARATOR
Intervention: Isometric exercises programme alone
Number of subjects: 44
Study 33619178 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability of vaccine efficacy (50%, 70%, or 90%)
Number of subjects: 1000
Study 33619178 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability of minor side effects (50%, 75%, 90%)
Number of subjects: 1000
Study 33619178 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse reaction rates (1/100,000, 1/million, 1/100 million)
Number of subjects: 1000
Study 33619178 — intervention group
Group type: EXPERIMENTAL
Intervention: Announcement of vaccines being 95% effective
Number of subjects: 1000
Study 33619178 — intervention group
Group type: EXPERIMENTAL
Intervention: Expected benefit vs. expected side effects
Number of subjects: 1000
Study 32593069 — intervention group
Group type: EXPERIMENTAL
Intervention: Climbing Intervention (CI)
Number of subjects: 33
Study 32593069 — intervention group
Group type: COMPARATOR
Intervention: Swimming Intervention (SI)
Number of subjects: 33
Study 32593069 — intervention group
Group type: COMPARATOR
Intervention: Occupational Therapy Intervention (OTI)
Number of subjects: 33
Study 36066264 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal cannula (HFNC) therapy
Number of subjects: 11715
Study 36066264 — intervention group
Group type: COMPARATOR
Intervention: Oxygen therapy without HFNC
Number of subjects: 11715
Study 34400532 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 0
Study 34400532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35079985 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 1000
Study 35079985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 33124900 — intervention group
Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI 100/62.5/25 µg
Number of subjects: 10355
Study 33124900 — intervention group
Group type: COMPARATOR
Intervention: FF/VI 100/25 µg
Number of subjects: 10355
Study 33124900 — intervention group
Group type: COMPARATOR
Intervention: UMEC/VI 62.5/25 µg
Number of subjects: 10355
Study 36368914 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.2 mg·kg‐1 intravenously)
Number of subjects: 120
Study 36368914 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 120
Study 33904921 — intervention group
Group type: EXPERIMENTAL
Intervention: mySmartSkin (MSS)
Number of subjects: 0
Study 33904921 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 35342769 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors (canagliflozin) 100 mg/day
Number of subjects: 20019
Study 35342769 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors (empagliflozin) 10 mg/day
Number of subjects: 20019
Study 35342769 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors (ertugliflozin) 5 mg/day
Number of subjects: 20019
Study 35342769 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors (ipragliflozin) 50 mg/day
Number of subjects: 20019
Study 35342769 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors (luseogliflozin) 2.5 mg/day
Number of subjects: 20019
Study 35342769 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors (tofogliflozin) 20 mg/day
Number of subjects: 20019
Study 32168273 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric orders requiring drug formulation manipulation (n=3925)
Number of subjects: 15722
Study 32168273 — intervention group
Group type: COMPARATOR
Intervention: Adult orders requiring drug formulation manipulation (n=1301)
Number of subjects: 15722
Study 32975703 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement with air‐powder abrasion
Number of subjects: 20
Study 32975703 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined mechanical‐chemical decontamination
Number of subjects: 20
Study 32975703 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical decontamination with hydrogen peroxide and chlorhexidine gluconate
Number of subjects: 20
Study 32975703 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 20
Study 32130142 — intervention group
Group type: EXPERIMENTAL
Intervention: Major self-management support intervention (personal email contacts with a dementia nurse, online videos, and e-bulletins)
Number of subjects: 81
Study 32130142 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium intervention (online videos and e-bulletins)
Number of subjects: 81
Study 32130142 — intervention group
Group type: COMPARATOR
Intervention: Minor intervention (e-bulletins only)
Number of subjects: 81
Study 35262646 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg
Number of subjects: 1609
Study 35262646 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg
Number of subjects: 1609
Study 35262646 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib (both doses)
Number of subjects: 1609
Study 33857028 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN) 50 mg
Number of subjects: 24
Study 33857028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33164066 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by chemoradiotherapy (Arm B)
Number of subjects: 100
Study 33164066 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy with concurrent S-1 (Arm A)
Number of subjects: 100
Study 32578813 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) group (allowed to ingest a carbohydrate-rich beverage two hours before surgery)
Number of subjects: 40
Study 32578813 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) group
Number of subjects: 40
Study 32578813 — intervention group
Group type: COMPARATOR
Intervention: Fasting group (absolute fasting after 00:00)
Number of subjects: 40
Study 32578813 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 34599686 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagal nerve stimulation (taVNS)
Number of subjects: 0
Study 34599686 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 33707991 — intervention group
Group type: COMPARATOR
Intervention: Active Play (CON)
Number of subjects: 52
Study 33707991 — intervention group
Group type: EXPERIMENTAL
Intervention: Locomotor Skills Guided Active Play (LOC)
Number of subjects: 52
Study 33707991 — intervention group
Group type: EXPERIMENTAL
Intervention: Object Control Skills Guided Active Play (OC)
Number of subjects: 52
Study 32900672 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjectives 'positive' vs. 'negative' (n=566)
Number of subjects: 1131
Study 32900672 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjectives 'abnormal' vs. 'normal' (n=565)
Number of subjects: 1131
Study 32900672 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 'positive' vs. 'negative' and 'abnormal' vs. 'normal'
Number of subjects: 1131
Study 32301388 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol combined with low-dose ketamine (0.25mg/kg propofol + 0.15mg/kg ketamine)
Number of subjects: 120
Study 32301388 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.25mg/kg)
Number of subjects: 120
Study 32301388 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.9% NaCl)
Number of subjects: 120
Study 32301388 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 32473378 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 275
Study 32473378 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 275
Study 32473378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 32473378 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 3 AnxA1 levels
Number of subjects: 275
Study 32473378 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 4 congestion score
Number of subjects: 275
Study 32473378 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiles 2 and 3 AnxA1 levels
Number of subjects: 275
Study 616733476 — intervention group
Group type: EXPERIMENTAL
Intervention: CD symptoms plus a diagnostic label and description of LPE traits
Number of subjects: 326
Study 616733476 — intervention group
Group type: EXPERIMENTAL
Intervention: CD symptoms plus a description of LPE traits and a 'psychopath' label
Number of subjects: 326
Study 616733476 — intervention group
Group type: COMPARATOR
Intervention: CD symptoms only
Number of subjects: 326
Study 616733476 — intervention group
Group type: COMPARATOR
Intervention: CD symptoms plus a diagnostic label
Number of subjects: 326
Study 34121665 — intervention group
Group type: EXPERIMENTAL
Intervention: CFLU mHealth tool
Number of subjects: 17
Study 32361667 — intervention group
Group type: EXPERIMENTAL
Intervention: Observer perspective (third-person)
Number of subjects: 112
Study 32361667 — intervention group
Group type: COMPARATOR
Intervention: Field perspective (first-person)
Number of subjects: 112
Study 35409646 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised exercise prescription (n = 24)
Number of subjects: 49
Study 35409646 — intervention group
Group type: COMPARATOR
Intervention: Standardised exercise prescription (n = 25)
Number of subjects: 49
Study 32115325 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth Aware of Mental Health (YAM) intervention
Number of subjects: 1878
Study 36095039 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 40
Study 36095039 — intervention group
Group type: COMPARATOR
Intervention: Book-listening regimen
Number of subjects: 40
Study 33561882 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonparametric statistical model for randomization tests
Number of subjects: 0
Study 33561882 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization tests
Number of subjects: 0
Study 33561882 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate imbalance
Number of subjects: 0
Study 36050726 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning methods applied to PROMs datasets
Number of subjects: 0
Study 36050726 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline measurements
Number of subjects: 0
Study 36050726 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification task
Number of subjects: 0
Study 36050726 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalizable machine learning pipelines
Number of subjects: 0
Study 36050726 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMs
Number of subjects: 0
Study 34130029 — intervention group
Group type: EXPERIMENTAL
Intervention: BALANCE Program
Number of subjects: 369
Study 34130029 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional nutrition advice)
Number of subjects: 369
Study 36229975 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 193
Study 36229975 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline sCD163 ≤ 500 pg/ml
Number of subjects: 193
Study 32903063 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan
Number of subjects: 22
Study 32903063 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal zolmitriptan
Number of subjects: 22
Study 32903063 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan 50 mg
Number of subjects: 22